explore -WSS

explore

author：hotspot 2025-08-24 09:38:01 - browse：8

Photo illustration of the FDA US Food and Drug website. -- health policy coverage from STAT — Adobe

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday.

The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility. An investigation found that the delayed response was due in part to the agency’s organization. A nonprofit, nonpartisan advisory body reported in December it was not clear who is in charge of food oversight, and agency food safety staff are siloed among divisions that don’t communicate with each other.

Although the food center has been the focus of attention in the reorganization, it will affect a huge swath of the agency. The reorganization is expected to impact about 8,000 FDA employees, according to Michael Rogers, FDA associate commissioner for regulatory affairs. The Office of Regulatory Affairs, which will be called the Office of Inspections and Investigations under the proposed reorganization, will go from having about 5,100 full-time employees to 3,586 employees.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： A revolution in caring for preterm infants

WSS

How should state employee insurance handle Wegovy?

Medicare proposal to cover medical devices draws a mixed reaction

Better Therapeutics data on benefit with GLP

Bernie Sanders bashes nonprofit hospitals over their tax breaks

There’s no way to know how good AI health technologies are

Affirmative action in medical school literally saved lives

focus

explore

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Anesthesiologist group: stop taking Ozempic before surgery

Supreme Court strikes down use of affirmative action

A revolution in caring for preterm infants

Peter Hotez and the public health issue of online harassment

The high cost of giving birth even with insurance

Bright Health sells Medicare Advantage business to Molina

Wildfire smoke exposes gaps in outdoor worker protections

Jerome Adams on the need for new antivirals for Covid

Wellcome Trust names Røttingen as its new CEO

focus

Takeaways from AdvaMed, the largest medical devices conference

Life sciences deals on track to hit lowest point since 2017

How doctors and nurses shape Google's AI

Researchers CRISPR chickens in bid to protect them from bird flu

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How doctors and nurses shape Google's AI

explore

leisure time

hotspot

hotspot